Modulation of apolipoprotein A-IV lipid binding by an interaction between the N and C termini

Matthew R. Tubb, R. A.Gangani D. Silva, Kevin J. Pearson, Patrick Tso, Min Liu, W. Sean Davidson

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Apolipoprotein A-IV (apoA-IV) is a 376-amino acid exchangeable apolipoprotein made in the small intestine of humans. Although it has many proposed roles in vascular disease, satiety, and chylomicron metabolism, there is no known structural basis for these functions. The ability to associate with lipids may be a key step in apoA-IV functionality. We recently identified a single amino acid, Phe334, which seems to inhibit the lipid binding capability of apoA-IV. We also found that an intact N terminus was necessary for increased lipid binding of Phe334 mutants. Here, we identify Trp12 and Phe15 as the N-terminal amino acids required for the fast lipid binding seen with the F334A mutant. Furthermore, we found that individual disruption of putative amphipathic α-helices 3-11 had little effect on lipid binding, suggesting that theNterminus of apoA-IV may be the operational site for initial lipid binding. We also provide three independent pieces of experimental evidence supporting a direct intramolecular interaction between sequences near amino acids 12/15 and 334. This interaction could represent a unique "switch" mechanism by which apoA-IV changes lipid avidity in vivo.

Original languageEnglish
Pages (from-to)28385-28394
Number of pages10
JournalJournal of Biological Chemistry
Issue number39
StatePublished - Sep 28 2007

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Modulation of apolipoprotein A-IV lipid binding by an interaction between the N and C termini'. Together they form a unique fingerprint.

Cite this